```html

Rhabdoviridae Encephalitis (Rabies) – A Comprehensive Medical Guide

Overview

Rhabdoviridae encephalitis most commonly refers to rabies, a viral infection of the central nervous system caused by members of the Rhabdoviridae family. The virus travels from a bite or abrasion to the brain, where it causes an acute, progressive, and ultimately fatal encephalitis if untreated.

• Who it affects: All mammals are susceptible, but humans acquire rabies almost exclusively through the bite or saliva of infected animals—most often dogs, bats, raccoons, skunks, and foxes.
• Global prevalence: The World Health Organization estimates 59,000 human deaths per year worldwide, >99% of which occur in Asia and Africa where dog‑mediated transmission remains common [WHO, 2023]. In the United States, ~1–3 human cases are reported annually, mainly linked to bat exposures [CDC, 2024].
• Age distribution: In endemic regions, children <15 years old account for ~40 % of cases because they are more likely to approach stray animals.

Symptoms

Rabies incubation varies from 1–3 months (range: 5 days–1 year) and depends on viral load, site of entry, and distance to the central nervous system. Once symptoms appear, the disease progresses rapidly (usually within 2–10 days). The classic presentation can be divided into three phases.

1. Prodromal (early) phase

• Pain or paresthesia at the bite site (often the first clue).
• Fever, headache, malaise. These nonspecific signs may mimic flu.
• Generalized fatigue and loss of appetite.

2. Furious (encephalitic) phase – most common (≈70 %)

• Hyperactivity & agitation – extreme restlessness, inability to stay still.
• Hydrophobia – fear of water due to painful throat spasms when swallowing.
• Aerophobia – aversion to air currents or wind.
• Excessive salivation & foaming at the mouth.
• Muscle spasms & seizures – often beginning in the limbs and spreading to the trunk.
• Confusion, hallucinations, and delirium.

3. Paralytic (dumb) phase – ~30 % of cases

• Gradual paralysis beginning at the site of the bite and spreading proximally.
• Weakness of facial muscles → drooping eyelids, difficulty speaking.
• Loss of reflexes and eventual coma.
• Less prominent hydrophobia than the furious form.

Both forms inevitably lead to coma and death within 7–10 days after symptom onset if no life‑saving experimental therapy is applied.

Causes and Risk Factors

Cause

Rabies is caused by any of >14 recognized lyssavirus species within the Rhabdoviridae family. The classic “rabies virus” (Rabies lyssavirus) accounts for >99 % of human infections.

Transmission pathways

• Bite wounds (most common) – virus present in saliva.
• Scratches or mucosal contact with infected saliva.
• Organ transplantation – extremely rare.

Risk factors

• Living in or traveling to areas with uncontrolled stray‑dog populations.
• Occupations with frequent animal contact (veterinarians, wildlife rehabilitators, animal control officers).
• Camping, hiking, or caving in regions where bat colonies roost.
• Failure to receive appropriate post‑exposure prophylaxis (PEP) after potential exposure.
• Immunocompromised status may increase susceptibility, though most infections are dose‑dependent rather than immune‑dependent.

Diagnosis

Because once clinical disease appears it is almost uniformly fatal, rapid diagnosis is essential for two reasons: (1) to confirm the need for emergency PEP in close contacts and (2) to enroll the patient in experimental protocols.

Clinical assessment

• Detailed exposure history (bite, animal type, vaccination status).
• Neurological exam focusing on hydrophobia, hyperactivity, and cranial‑nerve deficits.

Laboratory tests

1. Direct Fluorescent Antibody (DFA) test – gold standard on skin‑suckle biopsy from the nape of the neck or on brain tissue (post‑mortem).
2. Reverse‑transcriptase PCR (RT‑PCR) – detects viral RNA in saliva, cerebrospinal fluid (CSF), or tissue; useful early in disease.
3. Serology – detection of rabies‑virus–specific IgM/IgG in serum or CSF; becomes positive only after the immune response is mounted (often late).
4. CSF analysis – typically shows a mild lymphocytic pleocytosis, elevated protein, and normal glucose.
5. Imaging – MRI may reveal hyperintensity in the brainstem, hippocampus, or thalamus but is not diagnostic.

Post‑exposure testing

If a bite occurs, the animal should be observed or tested. If the animal is unavailable or tests positive, initiate PEP without waiting for laboratory confirmation.

Treatment Options

Once symptoms develop, there is no universally effective cure, but aggressive supportive care and experimental protocols (e.g., the Milwaukee protocol) may extend survival in isolated cases. The cornerstone of rabies management is **prevention** through timely post‑exposure prophylaxis.

Post‑Exposure Prophylaxis (PEP)

1. Wound care – immediate thorough washing with soap and running water for at least 15 minutes; apply 10% povidone‑iodine if available.
2. Rabies‑immune globulin (RIG) – 20 IU/kg infiltrated around the wound site (only 1 mL for each cm of wound depth).
3. Vaccine series – a modern inactivated vaccine (e.g., purified chick embryo cell – PCECV, or human diploid cell vaccine – HDCV) given on days 0, 3, 7, 14, and (for immunocompromised) day 28. Intradermal schedules are WHO‑approved for resource‑limited settings.

Symptomatic & Supportive Care (after symptom onset)

• Intensive care unit (ICU) monitoring for airway protection, seizure control (benzodiazepines, phenobarbital), and autonomic instability.
• Ventilatory support – patients often require mechanical ventilation due to respiratory muscle paralysis.
• Cooling (targeted temperature management) – used experimentally to reduce viral replication.
• Experimental antiviral combinations (ribavirin, interferon‑α) – have not shown consistent benefit in controlled trials.

Experimental Therapeutic Approaches

Few patients survive once clinical rabies manifests. The “Milwaukee protocol” (induced therapeutic coma, antiviral agents, and aggressive ICU support) reported a handful of survivors, but subsequent attempts have largely failed. Participation in a clinical trial is recommended when available.

Living with Rhabdoviridae Encephalitis (e.g., Rabies)

Because symptomatic rabies is essentially fatal, the “living with” section focuses on patients who have received full PEP after exposure, as well as families coping with severe anxiety about the disease.

• Follow‑up vaccination – complete the vaccine series; antibody titers are usually checked 2–4 weeks after the final dose (≥0.5 IU/mL is considered protective).
• Psychological support – exposure anxiety is common; counseling or support groups can reduce distress.
• Pet vaccination – keep dogs, cats, and ferrets up‑to‑date on rabies immunizations (annual or triennial depending on local law).
• Travel preparation – if traveling to high‑risk regions, pack a rabies vaccine schedule and know where local medical facilities are.
• Medical alert identification – consider a bracelet noting “Received rabies PEP, 2024” for emergency personnel.

Prevention

1. Vaccinate animals – mandatory dog vaccination programs have reduced human cases by >95 % in many Latin‑American countries [PAHO, 2022].
2. Avoid wildlife contact – do not handle bats, raccoons, skunks, or foxes. If a bat is found in a living area, contact public health authorities.
3. Safe outdoor practices – wear gloves when gardening; use flashlights at night to avoid startling bats.
4. Pre‑exposure prophylaxis (PrEP) for high‑risk groups (vets, animal‑control workers, spelunkers): three vaccine doses on days 0, 7, 21 or 28, followed by booster titers every 2–3 years.
5. Prompt wound care – immediate washing and medical evaluation after any animal bite or scratch.
6. Public education – community outreach about responsible pet ownership and the importance of reporting animal bites.

Complications

If untreated, rabies leads to irreversible brain damage and death. Survivors of the rare symptomatic cases may experience long‑term neurological sequelae:

• Chronic cognitive deficits (memory, attention).
• Persistent dysphagia and vocal cord paralysis.
• Seizure disorder requiring long‑term anticonvulsants.
• Psychiatric sequelae – anxiety, depression, post‑traumatic stress.

When to Seek Emergency Care

References

• World Health Organization. Rabies Fact Sheet. 2023.
• Centers for Disease Control and Prevention. Rabies – CDC. Updated 2024.
• Mayo Clinic. Rabies – Symptoms & Causes. Accessed June 2024.
• National Institute of Neurological Disorders and Stroke. Rabies Information Page. 2023.
• Cleveland Clinic. Rabies – Overview. 2024.
• Hampson K, et al. The global burden of rabies. Lancet Infect Dis. 2022;22(5): 711‑720.

```